Pathologists, I-SPY 2 TRIAL Investigators and

Residual cancer burden (RCB) as prognostic in the I-SPY 2 TRIAL.

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 520-520

10.1200/jco.2018.36.15_suppl.520